Document:

Exhibit 4.3

 

STAGWELL INC. 

 

SECOND AMENDED AND RESTATED 2016 STOCK INCENTIVE
PLAN 

 

1.            Purpose
of the Plan.

 

This Stagwell Inc. Second
Amended and Restated 2016 Stock Incentive Plan is intended to promote the interests of the Company and its shareholders by providing the
employees and consultants of the Company and eligible non-employee directors of the Company, who are largely responsible for the management,
growth and protection of the business of the Company, with incentives and rewards to encourage them to continue in the service of the
Company. The Plan is designed to meet this intent by providing such employees, consultants and eligible non-employee directors with a
proprietary interest in pursuing the long-term growth, profitability and financial success of the Company.

 

This Plan constitutes an amendment
and restatement of the MDC Partners Inc. Amended and Restated 2016 Stock Incentive Plan (the “Prior 2016 Plan”), which was
approved by the Company’s shareholders on June 1, 2016. The Prior 2016 Plan was subsequently amended on June 6, 2018, following
approval by the Board of Directors and the Company’s shareholders. The Prior 2016 Plan was amended and restated on June 25, 2020,
following approval by the Board of Directors and the Company’s shareholders. The Prior 2016 Plan was amended on December 14, 2021,
subject to shareholder approval.

 

2.            Definitions.

 

As used in the Plan, the following
definitions apply to the terms indicated below:

 

(a)           “Affiliate”
means (i) any Subsidiary; and (ii) any domestic eligible entity that is disregarded, under Treasury Regulation Section 301.7701-3, as
an entity separate from either (A) the Company or (B) any Subsidiary.

 

(b)           “Allowed
Transferee” means, with respect to any Participant, any “family member” of the Participant, as defined in the General
Instructions to Form S-8 under the Exchange Act.

 

(c)           “Board
of Directors” means the Board of Directors of the Company.

 

(d)           “Change
in Control” means the occurrence of any of the following:

 

(i)            With
respect to Incentive Awards granted prior to August 2, 2021, a Change in Control occurred on August 2, 2021.

 

(ii)           With
respect to Incentive Awards granted on or after August 2, 2021:

 

(A)          any
 “person” or “group” of related persons other than Stagwell Media and any of its Permitted Transferees is or becomes
the “beneficial owner” (within the meaning of Rule 13d-3 promulgated under the Exchange Act, a “Beneficial Owner”),
directly or indirectly, in the aggregate of more than 50% of the total voting power of the Voting Stock of the Company; provided, that
the formation of a holding company to hold Capital Stock of the Company which does not change the beneficial ownership of such Capital
Stock (except as a result of the exercise of dissenters’ rights) will not constitute a Change in Control under this paragraph (A)
(provided that, from and after the formation of such holding company, all references to the Company in this definition shall instead refer
to such holding company);

 

(B)           during
any period of two consecutive years, individuals who at the beginning of such period constituted the Board of Directors, together with
any new directors whose election by such Board of Directors or whose nomination for election by the shareholders of the Company was approved
by a vote of a majority of the directors of the Company then still in office who were either directors at the beginning of such period
or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board of
Directors then in office;

 

(C)           the
liquidation or dissolution of the Company; or

 

     

     

    

 

(D)          the
Company consolidates with, or merges with or into, another Person, or the Company sells, conveys, assigns, transfers, leases or otherwise
disposes of all or substantially all of the assets of the Company, determined on a consolidated basis, to any Person, other than a transaction
where the Person or Persons that, immediately prior to such transaction, beneficially owned the outstanding Voting Stock of the Company
are, by virtue of such prior ownership, the beneficial owners in the aggregate of a majority of the total voting power of the then outstanding
Voting Stock of the surviving or transferee Person (or if such surviving or transferee Person is a direct or indirect wholly-owned subsidiary
of another Person, such Person who is the ultimate parent entity) (provided that, in the event the exception in this paragraph (D) applies,
then, from and after the consummation of such transaction, all references to the Company in this definition shall instead refer to such
surviving or transferee Person or ultimate parent entity); provided, however, that a Change in Control shall not be deemed
to occur by reason of (I) an acquisition of Voting Stock directly by an employee benefit plan (or a trust forming a part thereof)
maintained by the Company or any Person of which a majority of its voting power or its voting equity securities or equity interest is
owned, directly or indirectly, by the Company, or (II) following such a transaction the individuals who immediately prior to the
consummation of the such transaction constituted a majority of the Board of Directors constitute a majority of the board of directors
(or similar governing body) of the surviving or transferee Person.

 

For purposes of this
definition:

 

(I)            “Business
Combination” means, collectively, the transactions consummated pursuant to the Transaction Agreement, dated as of December 21, 2020,
by any among Stagwell Media, MDC Partners Inc., a Canadian corporation which domesticated as a Delaware corporation and converted into
Stagwell Global LLC pursuant to a certificate of conversion filed in the office of the Secretary of State of the State of Delaware, the
Company and Midas Merger Sub 1 LLC, a Delaware limited liability company, as amended.

 

(II)          “Capital
Stock” means: (a) with respect to any Person that is a corporation, any and all shares, interests, participations or other
equivalents (however designated and whether or not voting) of capital stock, including each class of common stock and preferred stock
of such Person and stock appreciation rights; (b) with respect to any Person that is not a corporation, any and all partnership or
other equity or ownership interests of such Person; and (c) any warrants, rights or options to purchase any of the instruments or
interests referred to in paragraphs (a) or (b) of this definition.

 

(III)         “Permitted
Transferee” means, with respect to Stagwell Media, (a) any successor entity owned and controlled solely by the same Persons
that own and control Stagwell Media prior to such transfer; and (b) an Affiliate, general partner or limited partner or a holder,
as of immediately prior to the closing of the Business Combination, of an equity interest, equity award or equity-related award in an
entity contributed by Stagwell Media to Stagwell Global in connection with the Business Combination.

 

(IV)         “Stagwell
Global” means Stagwell Global LLC, a Delaware limited liability company.

 

(V)          “Stagwell
Media” means Stagwell Media LP, a Delaware limited partnership.

 

(VI)         “Voting
Stock” means, with respect to any Person, securities of any class of Capital Stock of such Person entitling the holders thereof
(whether at all times or only so long as no senior class of stock has voting power by reason of any contingency) to vote in the election
of members of the board of directors (or equivalent governing body) of such Person.

 

    2

     

    

 

Notwithstanding the foregoing,
a Change in Control shall not be deemed to occur solely because any Person (the “Subject Person”) becomes the Beneficial Owner
of more than the permitted amount of the outstanding Voting Stock as a result of the acquisition of Voting Stock by the Company which,
by reducing the number of Voting Stock outstanding, increases the proportional number of shares Beneficially Owned by the Subject Persons,
provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Stock
by the Company, and after such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting
Stock which increases the percentage of the then outstanding Voting Stock Beneficially Owned by the Subject Person, then a Change in Control
shall occur.

 

(e)           “Class
A Shares” means the Company’s Class A Common Stock, par value $0.001 per share, or any other security into which such shares
shall be changed pursuant to the adjustment provisions of Section 10 of the Plan.

 

(f)            “Code”
means the Internal Revenue Code of 1986, as amended from time to time.

 

(g)           “Committee”
means the Human Resources & Compensation Committee of the Board of Directors or such other committee as the Board of Directors shall
appoint from time to time to administer the Plan and to otherwise exercise and perform the authority and functions assigned to the Committee
under the terms of the Plan.

 

(h)           “Company”
means Stagwell Inc., a Delaware corporation, and each of its Subsidiaries, collectively.

 

(i)            “Director”
means a member of the Board of Directors who is not at the time of reference an employee of the Company.

 

(j)            “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(k)           “Fair
Market Value” means, with respect to a Class A Share, as of the applicable date of determination (i) the closing sales price on
the immediately preceding business day of Class A Shares as reported on the principal securities exchange on which such shares are then
listed or admitted to trading or (ii) if not so reported, the average of the closing bid and ask prices on the immediately preceding business
day as reported on the National Association of Securities Dealers Automated Quotation System or (iii) if not so reported, as furnished
by any member of the National Association of Securities Dealers, Inc. selected by the Committee. In the event that the price of Class
A Shares shall not be so reported, the Fair Market Value of Class A Shares shall be determined by the Committee in its absolute discretion.

 

(l)            “Incentive
Award” means an Option, SAR or Other Stock-Based Award granted to a Participant pursuant to the terms of the Plan.

 

(m)          “Option”
means a non-qualified stock option to purchase Class A Shares granted to a Participant pursuant to Section 6.

 

(n)           “Other
Stock-Based Award” means an equity or equity-related award granted to a Participant pursuant to Section 8, including without limitation
a restricted stock award.

 

(o)           “Participant”
means any director, officer, employee or consultant (including any prospective director, officer, employee or consultant) of the Company
or its Affiliates who is an “employee” within the meaning of Form S-8 under the Exchange Act, as in effect from time to time,
who is selected by the Committee or the Board of Directors to receive an Incentive Award.

 

(p)           “Performance
Measures” means such measures as are described in Section 9 on which performance goals are based.

 

(q)           “Permitted
Acceleration Event” means (i) with respect to any Incentive Award that is subject to performance-based vesting, the full or partial
vesting of such Incentive Award based on satisfaction of the applicable performance-based conditions, (ii) the occurrence of a Change
in Control or an event described in Section 10(b), (c) or (d) or (iii) any termination of the employment of a Participant, other than
a termination for cause (as defined by the Committee) or voluntary termination prior to retirement (as defined by the Committee).

 

    3

     

    

 

(r)            “Person”
means a “person” as such term is used in Section 13(d) and 14(d) of the Exchange Act.

 

(s)           “Plan”
means this Stagwell Inc. Second Amended and Restated 2016 Stock Incentive Plan, as it may be amended from time to time.

 

(t)            “SAR”
means a stock appreciation right granted to a Participant pursuant to Section 7.

 

(u)           “Section
409A” means Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder,
including, without limitation, any such regulations or other guidance that may be issued after the date the Plan is adopted by the Board
of Directors.

 

(v)           “Securities
Act” means the Securities Act of 1933, as amended.

 

(w)          “Subsidiary”
means any “subsidiary corporation” within the meaning of Section 424(f) of the Code or any other entity that the Committee
determines from time to time should be treated as a subsidiary corporation for purposes of this Plan.

 

3.            Stock
Subject to the Plan; Additional Limitations.

 

(a)           In
General.

 

Subject to adjustment as provided
in Section 10 and the following provisions of this Section 3, the maximum number of Class A Shares that may be covered by Incentive Awards
granted under the Plan shall not exceed 20,250,000 Class A Shares. Such share reserve includes (i) the 5,250,000 Class A Shares
reserved for issuance under the Prior 2016 Plan prior to December 14, 2021, plus (ii) the 1,312,000 Class A Shares reserved for issuance
under the Prior 2016 Plan on December 14, 2021, subject to shareholder approval at the Company’s 2022 Annual Meeting of Shareholders,
plus (iii) an increase of 13,688,000 Class A Shares approved by the Board of Directors on March 7, 2022, subject to shareholder approval
at the Company’s 2022 Annual Meeting of Shareholders. Class A Shares issued under the Plan may be either authorized and unissued
shares or treasury shares, or both, at the discretion of the Committee.

 

For purposes of the preceding
paragraph, Class A Shares covered by Incentive Awards shall only be counted as used to the extent they are actually issued and delivered
to a Participant (or such Participant’s permitted transferees as described in the Plan) pursuant to the Plan. For purposes of clarification,
in accordance with the preceding sentence if Class A Shares are withheld to satisfy any tax withholding requirement in connection with
an Other Stock-Based Award only the shares issued (if any), net of the shares withheld, will be deemed delivered for purposes of determining
the number of Class A Shares that are available for delivery under the Plan.

 

(b)           Prohibition
on Substitutions and Repricings for Outstanding Incentive Awards Under the Plan.

 

In no event shall any new
Incentive Awards be issued in substitution for outstanding Incentive Awards previously granted to Participants under the Plan, nor shall
any Option or SAR (i) be amended to decrease the exercise price thereof, (ii) be canceled at a time when its exercise price exceeds the
Fair Market Value of the underlying Class A Shares in exchange for another Incentive Award, award under any other equity-compensation
plan or any cash payment or (iii) be subject to any action that would be treated, for accounting purposes, as a “repricing”
of such Option or SAR, unless such amendment, cancelation or action is approved by the Company’s shareholders. For the avoidance
of doubt, an adjustment to the exercise price of an Option or SAR that is made in accordance with Section 10 shall not be considered a
reduction in exercise price or “repricing” of such Option or SAR.

 

(c)           Annual
Limitation on Grants.

 

Each independent Director
shall not receive equity awards (including any Incentive Awards issued under the Plan) with an aggregate value in excess of $250,000 in
any given fiscal year (based on grant date fair value determined in accordance with U.S. generally accepted accounting principles). Any
Incentive Awards (or any other equity awards) granted to an individual for his or her services as an employee, or for his or her services
as a consultant (other than as a Director), will not be subject to the annual limits set forth in this paragraph (c).

 

    4

     

    

 

Any such compensation that is deferred will be
counted toward the annual limits set forth in this paragraph (c) for the year in which it was first earned, and not when paid or settled
(if later).

 

(d)           Minimum
Vesting Period of One (1) Year for All Incentive Awards.

 

In no event shall any new
Incentive Award granted under this Plan vest or otherwise become payable earlier than one (1) year following the date on which it is granted,
other than upon the occurrence of a Permitted Acceleration Event; provided, however, that, notwithstanding the foregoing,
the minimum vesting requirement of this paragraph (d) shall not apply to: (i) any Substitute Awards, (ii) any Incentive Awards delivered
in lieu of fully-vested cash awards or payments, (iii) any Incentive Awards to non-employee directors for which the vesting period runs
from the date of one annual meeting of the Company’s shareholders to the next annual meeting of the Company’s shareholders,
or (iv) any other Incentive Awards granted by the Committee from time to time that result in the issuance of an aggregate of up to five
percent (5) % of the Class A Shares available for issuance under paragraph (a) as of the effective date of the Plan; provided that,
nothing in this paragraph (d) limits the ability of an Incentive Award to provide that such minimum vesting restrictions may lapse or
be waived upon a Participant’s termination of service or death or disability.

 

(e)           Substitute
Awards.

 

Incentive Awards may be granted
under the Plan in assumption of, or in substitution for, outstanding awards previously granted by the Company or a company acquired by
the Company or with which the Company combines (“Substitute Awards”); provided, however, that in no event may any Substitute
Award be granted in a manner that would violate the prohibitions on substituting and repricing of Incentive Awards set forth in Section
3(b). The number of Class A Shares underlying any Substitute Awards shall not be counted against the share reserve set forth in Section
3(a).

 

(f)            Effect
of Change in Control.

 

Any new Incentive Award granted
under this Plan that is subject to time-based vesting terms and conditions shall not become fully and immediately vested and exercisable
solely as a result of the occurrence of a Change in Control, absent a termination of employment without cause or a resignation for good
reason following any such Change in Control. Any new Incentive Award granted under this Plan that is subject to performance-based vesting
terms and conditions shall not become fully and immediately vested and exercisable solely as a result of the occurrence of a Change in
Control, absent a termination of employment without cause or a resignation for good reason following any such Change in Control and shall
be adjusted on a pro-rata basis as determined by the Committee.

 

4.            Administration
of the Plan.

 

The Plan shall be administered
by a Committee of the Board of Directors consisting of two or more persons, each of whom qualify as non-employee directors (within the
meaning of Rule 16b-3 promulgated under Section 16 of the Exchange Act). The Committee shall, consistent with the terms of the Plan, from
time to time designate those who shall be granted Incentive Awards under the Plan and the amount, type and other terms and conditions
of such Incentive Awards. All of the powers and responsibilities of the Committee under the Plan may be delegated by the Committee, in
writing, to any subcommittee thereof. In addition, the Committee may from time to time authorize a committee consisting of one or more
Directors to grant Incentive Awards to persons who are not “executive officers” of the Company (within the meaning of Rule
16a-1 under the Exchange Act), subject to such restrictions and limitation as the Committee may specify. In addition, the Board of Directors
may, consistent with the terms of the Plan, from time to time grant Incentive Awards to Directors.

 

The Committee shall have
full discretionary authority to administer the Plan, including discretionary authority to interpret and construe any and all
provisions of the Plan and the terms of any Incentive Award (and any agreement evidencing any Incentive Award) granted thereunder
and to adopt and amend from time to time such rules and regulations for the administration of the Plan as the Committee may deem
necessary or appropriate. Without limiting the generality of the foregoing, (i) the Committee shall determine whether an authorized
leave of absence, or absence in military or government service, shall constitute termination of service and (ii) the services of a
Participant with the Company shall be deemed to have terminated for all purposes of the Plan if such person is employed by or
provides services to a Person that is an Affiliate of the Company and such Person ceases to be an Affiliate of the Company, unless
the Committee determines otherwise. Decisions of the Committee shall be final, binding and conclusive on all parties.

 

    5

     

    

 

On or after the date of grant
of an Incentive Award under the Plan, the Committee may (i) extend the term of any such Incentive Award, including, without limitation,
extending the period following a termination of a Participant’s service during which any such Incentive Award may remain outstanding,
(ii) waive any conditions to the exercisability or transferability, as the case may be, of any such Incentive Award or (iii) provide for
the payment of dividends or dividend equivalents with respect to any such Incentive Award that is not an Option or SAR, when and to the
extent such Incentive Award has vested (including satisfying any applicable performance-based vesting requirements).

 

No member of the Committee
shall be liable for any action, omission, or determination relating to the Plan, and the Company shall indemnify and hold harmless each
member of the Committee and each other director or employee of the Company to whom any duty or power relating to the administration or
interpretation of the Plan has been delegated against any cost or expense (including counsel fees) or liability (including any sum paid
in settlement of a claim with the approval of the Committee) arising out of any action, omission or determination relating to the Plan,
unless, in either case, such action, omission or determination was taken or made by such member, director or employee in bad faith and
without reasonable belief that it was in the best interests of the Company.

 

5.            Eligibility.

 

The Persons who shall be eligible
to receive Incentive Awards pursuant to the Plan shall be any director, officer, employee or consultant (including any prospective director,
officer, employee or consultant) of the Company or its Affiliates who is an “employee” within the meaning of Form S-8 under
the Exchange Act, as in effect from time to time. All Incentive Awards granted under the Plan shall be evidenced by a separate written
agreement entered into by the Company and the recipient of such Incentive Award.

 

6.            Options.

 

The Committee may from time
to time grant Options, subject to the following terms and conditions:

 

(a)           Exercise
Price.

 

The exercise price per Class
A Share covered by any Option shall be not less than 100% of the Fair Market Value of a Class A Share on the date on which such Option
is granted.

 

(b)           Term
and Exercise of Options.

 

(i)            Each
Option shall become vested and exercisable on such date or dates, during such period and for such number of Class A Shares as shall be
determined by the Committee on or after the date such Option is granted; provided, however that no Option shall be exercisable
after the expiration of ten years from the date such Option is granted; provided, further, that other than as set forth
in Section 3(e), no Option shall become exercisable earlier than one year after the date on which it is granted; and, provided,
further, that each Option shall be subject to earlier termination, expiration or cancellation as provided in the Plan or in the
agreement evidencing such Option.

 

(ii)           Each
Option may be exercised in whole or in part; provided, however that no partial exercise of an Option shall be for an aggregate
exercise price of less than $1,000. The partial exercise of an Option shall not cause the expiration, termination or cancellation of the
remaining portion thereof.

 

(iii)          An
Option shall be exercised by such methods and procedures as the Committee determines from time to time, including without limitation through
net physical settlement or other method of cashless exercise.

 

(c)           Effect
of Termination of Service or other Relationship.

 

The agreement evidencing the
award of each Option shall specify the consequences with respect to such Option of the termination of the employment, service as a director
or other relationship between the Company and the Participant holding the Option.

 

    6

     

    

 

7.            Stock
Appreciation Rights.

 

The Committee may from time
to time grant SARs, subject to the following terms and conditions:

 

(a)           Stand-Alone
and Tandem; Cash and Stock-Settled.

 

SARs may be granted on a stand-alone
basis or in tandem with an Option. Tandem SARs may be granted contemporaneously with or after the grant of the Options to which they relate.
SARs may be settled in Class A Shares or in cash.

 

(b)           Exercise
Price.

 

The exercise price per Class
A Share covered by any SAR shall be not less than 100% of the Fair Market Value of a Class A Share on the date on which such SAR is granted;
provided, however that the exercise price of an SAR that is tandem to an Option and that is granted after the grant of such
Option may have an exercise price less than 100% of the Fair Market Value of a Class A Share on the date on which such SAR is granted
provided that such exercise price is at least equal to the exercise price of the related Option.

 

(c)           Benefit
Upon Exercise.

 

The exercise of an SAR with
respect to any number of Class A Shares shall entitle the Participant to (i) a cash payment, for each such share, equal to the excess
of (A) the Fair Market Value of a Class A Share on the effective date of such exercise over (B) the per share exercise price of the SAR,
(ii) the issuance or transfer to the Participant of the greatest number of whole Class A Shares which on the date of the exercise of the
SAR have an aggregate Fair Market Value equal to such excess or (iii) a combination of cash and Class A Shares in amounts equal to such
excess, as determined by the Committee. Such payment, transfer or issuance shall occur as soon as practical, but in no event later than
five business days, after the effective date of exercise.

 

(d)           Term
and Exercise of SARs.

 

(i)            Each
SAR shall become vested and exercisable on such date or dates, during such period and for such number of Class A Shares as shall be determined
by the Committee on or after the date such SAR is granted; provided, however that no SAR shall be exercisable after the
expiration of ten years from the date such SAR is granted; provided, further, that other than as set forth in Section 3(e),
no SAR shall become exercisable earlier than one year after the date on which it is granted; and, provided, further, that
each SAR shall be subject to earlier termination, expiration or cancellation as provided in the Plan or in the agreement evidencing such
SAR.

 

(ii)           Each
SAR may, to the extent vested and exercisable, be exercised in whole or in part; provided, however that no partial exercise
of an SAR shall be for an aggregate exercise price of less than $1,000. The partial exercise of an SAR shall not cause the expiration,
termination or cancellation of the remaining portion thereof.

 

(iii)          An
SAR shall be exercised by such methods and procedures as the Committee determines from time to time.

 

(iv)          The
exercise with respect to a number of Class A Shares of an SAR granted in tandem with an Option shall cause the immediate cancellation
of the Option with respect to the same number of shares. The exercise with respect to a number of Class A Shares of an Option to which
a tandem SAR relates shall cause the immediate cancellation of the SAR with respect to an equal number of shares.

 

(e)           Effect
of Termination of Service or other Relationship.

 

The agreement evidencing the
award of each SAR shall specify the consequences with respect to such SAR of the termination of the employment, service as a director
or other relationship between the Company and Participant holding the SAR.

 

    7

     

    

 

8.            Restricted
Stock Awards and Other Stock-Based Awards.

 

The Committee may grant
equity-based or equity-related awards not otherwise described herein in such amounts and subject to such terms and conditions as the
Committee shall determine. Without limiting the generality of the preceding sentence, each such Other Stock-Based Award may (a)
involve the transfer of actual Class A Shares to Participants, either at the time of grant or thereafter, or payment in cash or
otherwise of amounts based on the value of Class A Shares, (b) be subject to performance-based and/or service-based conditions, (c)
be in the form of phantom stock, restricted stock, restricted stock units, performance shares, or share-denominated performance
units and (d) be designed to comply with applicable laws of jurisdictions other than the United States.

 

9.            Performance
Measures.

 

The payment or vesting of
any Incentive Award to a Participant may relate to performance goals, including but not limited to one or more of the following Performance
Measures: revenue growth, achievement of EBITDA targets, operating income, operating cash flow, net income, earnings per share, cash earnings
per share, return on sales, return on assets, return on equity, return on invested capital and total shareholder return.

 

The measurement of any Performance
Measure(s) may exclude the impact of charges for restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring
items, and the cumulative effects of accounting changes, each as defined by generally accepted accounting principles and as identified
in the Company’s audited financial statements, including the notes thereto. Any Performance Measure(s) may be used to measure the
performance of the Company or an Affiliate as a whole or any business unit of the Company or any Affiliate or any combination thereof,
as the Committee may deem appropriate, or any of the above Performance Measures as compared to the performance of a group of comparator
companies, or a published or special index that the Committee, in its sole discretion, deems appropriate.

 

10.          Adjustment
Upon Changes in Class A Shares.

 

(a)           Shares
Available for Grants.

 

In the event of any change
in the number of Class A Shares outstanding by reason of any stock dividend or split, recapitalization, merger, consolidation, combination
or exchange of shares or similar corporate change, the maximum aggregate number of Class A Shares with respect to which the Committee
may grant Incentive Awards and the maximum aggregate number of Class A Shares with respect to which the Committee may grant Incentive
Awards to any individual Participant in any year shall be appropriately adjusted by the Committee. In the event of any change in the number
of Class A Shares outstanding by reason of any other similar event or transaction, the Committee may, but need not, make such adjustments
in the number and class of Class A Shares with respect to which Incentive Awards may be granted as the Committee may deem appropriate.

 

(b)           Increase
or Decrease in Issued Shares Without Consideration.

 

Subject to any required action
by the shareholders of the Company, in the event of any increase or decrease in the number of issued Class A Shares resulting from a subdivision
or consolidation of Class A Shares or the payment of a stock dividend (but only on the Class A Shares), or any other increase or decrease
in the number of such shares effected without receipt or payment of consideration by the Company, the Committee shall proportionally adjust
the number of Class A Shares subject to each outstanding Incentive Award and the exercise price per Class A Share of each such Incentive
Award.

 

(c)            Certain
Mergers.

 

Subject to any required action
by the shareholders of the Company, in the event that the Company shall be the surviving corporation in any merger or consolidation (except
a merger or consolidation as a result of which the holders of Class A Shares receive securities of another corporation), each Incentive
Award outstanding on the date of such merger or consolidation shall pertain to and apply to the securities which a holder of the number
of Class A Shares subject to such Incentive Award would have received in such merger or consolidation.

 

    8

     

    

 

(d)           Certain
Other Transactions.

 

In the event of (i) a
dissolution or liquidation of the Company, (ii) a sale of all or substantially all of the Company’s assets, (iii) a merger or
consolidation involving the Company in which the Company is not the surviving corporation or (iv) a merger or consolidation
involving the Company in which the Company is the surviving corporation but the holders of Class A Shares receive securities of
another corporation and/or other property, including cash, the Committee shall, in its absolute discretion, have the power to:

 

(i)            cancel,
effective immediately prior to the occurrence of such event, each Incentive Award (whether or not then exercisable), and, in full consideration
of such cancellation, pay to the Participant to whom such Incentive Award was granted an amount in cash, for each Class A Share subject
to such Incentive Award equal to the value, as determined by the Committee in its reasonable discretion, of such Incentive Award, provided
that with respect to any outstanding Option or SAR such value shall be equal to the excess of (A) the value, as determined by the Committee
in its reasonable discretion, of the property (including cash) received by the holder of Class A Shares as a result of such event over
(B) the exercise price of such Option or SAR, provided ̧ that each outstanding Option or SAR with an exercise price that is
equal to or greater than the value, as determined by the Committee in its reasonable discretion, of the property (including cash) received
by the holder of Class A Shares as a result of such event may be cancelled for no consideration; or

 

(ii)           provide
for the exchange of each Incentive Award (whether or not then exercisable or vested) for an incentive award with respect to, as appropriate,
some or all of the property which a holder of the number of Class A Shares subject to such Incentive Award would have received in such
transaction and, incident thereto, make an equitable adjustment as determined by the Committee in its reasonable discretion in the exercise
price of the incentive award, or the number of shares subject to the incentive award or, if appropriate, provide for a cash payment to
the Participant to whom such Incentive Award was granted in partial consideration for the exchange of the Incentive Award.

 

(e)            Other
Changes.

 

In the event of any change
in the capitalization of the Company or corporate change other than those specifically referred to in paragraphs (b), (c) or (d), the
Committee may, in its absolute discretion, make such adjustments in the number and class of shares subject to Incentive Awards outstanding
on the date on which such change occurs and in such other terms of such Incentive Awards as the Committee may consider appropriate to
prevent dilution or enlargement of rights.

 

(f)            No
Other Rights.

 

Except as expressly provided
in the Plan, no Participant shall have any rights by reason of any subdivision or consolidation of shares of stock of any class, the payment
of any dividend, any increase or decrease in the number of shares of stock of any class or any dissolution, liquidation, merger or consolidation
of the Company or any other corporation. Except as expressly provided in the Plan, no issuance by the Company of shares of stock of any
class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with
respect to, the number of Class A Shares subject to any Incentive Award.

 

11.           Rights
as a Shareholder.

 

No person shall have any rights
as a shareholder with respect to any Class A Shares covered by or relating to any Incentive Award granted pursuant to the Plan until the
date of the issuance of a stock certificate with respect to such shares. Except as otherwise expressly provided in Section 10 hereof,
no adjustment of any Incentive Award shall be made for dividends or other rights for which the record date occurs prior to the date such
stock certificate is issued.

 

In no circumstances shall
a cash dividend be paid in respect of unvested Incentive Awards. Cash dividends, if any, may be deferred at the discretion of the Committee
until the vesting date for any Incentive Award and distributed only to the extent Class A Shares underlying such Incentive Award ultimately
vest. Upon the forfeiture of any Incentive Award that does not vest, deferred dividends (if any) shall be forfeited back to the Company.

 

12.           No
Special Employment Rights; No Right to Incentive Award.

 

(a)            Nothing
contained in the Plan or any Incentive Award shall confer upon any Participant any right with respect to the continuation of his/her
employment by or service to the Company or interfere in any way with the right of the Company at any time to terminate such
employment or service or to increase or decrease the compensation of the Participant from the rate in existence at the time of the
grant of an Incentive Award.

 

    9

     

    

 

(b)           No
person shall have any claim or right to receive an Incentive Award hereunder. The Committee’s granting of an Incentive Award to
a Participant at any time shall neither require the Committee to grant an Incentive Award to such Participant or any other Participant
or other person at any time nor preclude the Committee from making subsequent grants to such Participant or any other Participant or other
person.

 

13.          Securities
Matters.

 

(a)            The
Company shall be under no obligation to effect the registration pursuant to the Securities Act of any Class A Shares to be issued hereunder
or to effect similar compliance under any state laws. Notwithstanding anything herein to the contrary, the Company shall not be obligated
to cause to be issued or delivered any certificates evidencing Class A Shares pursuant to the Plan unless and until the Company is advised
by its counsel that the issuance and delivery of such certificates is in compliance with all applicable laws, regulations of governmental
authority and the requirements of any securities exchange on which Class A Shares are traded and that the Participant has delivered all
notices and documents required to be delivered to the Company in connection therewith. The Committee may require, as a condition to the
issuance and delivery of certificates evidencing Class A Shares pursuant to the terms hereof, that the recipient of such shares make such
covenants, agreements and representations, and that such certificates bear such legends, as the Committee deems necessary or desirable.

 

(b)           The
exercise of any Option granted hereunder shall only be effective at such time as counsel to the Company shall have determined that the
issuance and delivery of Class A Shares pursuant to such exercise is in compliance with all applicable laws, regulations of governmental
authority and the requirements of any securities exchange on which Class A Shares are traded. The Company may, in its sole discretion,
defer the effectiveness of an exercise of an Option hereunder or the issuance or transfer of Class A Shares pursuant to any Incentive
Award pending or to ensure compliance under federal or state securities laws. The Company shall inform the Participant in writing of its
decision to defer the effectiveness of the exercise of an Option or the issuance or transfer of Class A Shares pursuant to any Incentive
Award. During the period that the effectiveness of the exercise of an Option has been deferred, the Participant may, by written notice,
withdraw such exercise and obtain the refund of any amount paid with respect thereto.

 

14.           Withholding
Taxes.

 

(a)            Cash
Remittance.

 

Whenever Class A Shares are
to be issued upon the exercise of an Option or the grant or vesting of an Incentive Award, the Company shall have the right to require
the Participant to remit to the Company in cash an amount sufficient to satisfy federal, state and local withholding tax requirements,
if any, attributable to such exercise, grant or vesting prior to the delivery of any certificate or certificates for such shares or the
effectiveness of the lapse of such restrictions. In addition, upon the exercise or settlement of any Incentive Award in cash, the Company
shall have the right to withhold from any cash payment required to be made pursuant thereto an amount sufficient to satisfy the federal,
state and local withholding tax requirements, if any, attributable to such exercise or settlement.

 

(b)           Stock
Remittance.

 

At the election of the Participant,
subject to the approval of the Committee, when Class A Shares are to be issued upon the exercise, grant or vesting of an Incentive Award,
the Participant may tender to the Company a number of Class A Shares that have been owned by the Participant for such period as the Committee
may determine having a Fair Market Value at the tender date determined by the Committee to be sufficient to satisfy the federal, state
and local withholding tax requirements, if any, attributable to such exercise, grant or vesting but not greater than such withholding
obligations. Such election shall satisfy the Participant’s obligations under Section 14(a) hereof, if any.

 

    10

     

    

 

(c)           Stock
Withholding.

 

At the election of the Participant,
subject to the approval of the Committee, when Class A Shares are to be issued upon the exercise, grant or vesting of an Incentive Award,
the Company shall withhold a number of such shares having a Fair Market Value at the exercise date determined by the Committee to be sufficient
to satisfy the federal, state and local withholding tax requirements, if any, attributable to such exercise, grant or vesting but not
greater than such withholding obligations. Such election shall satisfy the Participant’s obligations under Section 14(a) hereof,
if any; provided that, in the event Class A Shares are withheld in connection with the vesting of an Award of restricted stock, such withheld
Class A Shares shall be immediately cancelled by the Company and shall not constitute treasury Shares.

 

(d)           Broker-Assisted
Sales.

 

At the election of the Participant,
subject to the approval of the Committee, when Class A Shares are to be issued upon the exercise, grant or vesting of an Incentive Award,
the Participant may place a market sell order with a broker acceptable to the Company with respect to a number of such Class A Shares
having a Fair Market Value at the exercise date sufficient to satisfy the federal, state and local withholding tax requirements, if any,
attributable to such exercise, grant or vesting. Provided that the Participant delivers a written or electronic notice of such order to
the Company and the payment of such proceeds is made to the Company upon settlement of such sale, such election shall satisfy the Participant’s
obligations under Section 14(a) hereof, if any.

 

15.           Amendment
or Termination of the Plan.

 

The Board of Directors may
at any time suspend or discontinue the Plan or revise or amend it in any respect whatsoever; provided, however, that without
approval of the shareholders no revision or amendment shall except as provided in Section 10 hereof, (i) increase the number of Class
A Shares that may be issued under the Plan, (ii) expand the class of employees or other individuals eligible to participate in the Plan,
(iii) increase the annual limitation on grants to Directors (except for increases pursuant to Section 10), (iv) extend the expiration
date of the Plan, or (v) result in any amendment, cancellation or action described in Section 3(b) being permitted without the approval
of the Company’s shareholders. Nothing herein shall restrict the Committee’s ability to exercise its discretionary authority
hereunder pursuant to Section 4 hereof, which discretion may be exercised without amendment to the Plan. No action hereunder may, without
the consent of a Participant, reduce the Participant’s rights under any previously granted and outstanding Incentive Award. Nothing
herein shall limit the right of the Company to pay compensation of any kind outside the terms of the Plan.

 

16.           No
Obligation to Exercise.

 

The grant to a Participant
of an Option or SAR shall impose no obligation upon such Participant to exercise such Option or SAR.

 

17.           Transferability
of Incentive Awards.

 

(a)            Except
as otherwise provided in paragraphs (b) and (c):

 

(i)            No
Incentive Award under the Plan may be sold, pledged, assigned or transferred in any manner other than (A) by will or the laws of descent
and distribution or (B) subject to the consent of the Committee, pursuant to a domestic relations order, unless and until such Incentive
Award has been exercised or the Class A Shares underlying such Incentive Award have been issued, and all restrictions applicable to such
Class A Shares have lapsed;

 

(ii)           No
Incentive Award or interest or right therein shall be liable for or otherwise subject to the debts, contracts or engagements of the Participant
or the Participant’s successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, hypothecation,
encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy,
attachment, garnishment or any other legal or equitable proceedings (including bankruptcy) unless and until such Incentive Award has been
exercised, or the Class A Shares underlying such Incentive Award have been issued, and all restrictions applicable to such Class A Shares
have lapsed, and any attempted disposition of an Incentive Award prior to satisfaction of these conditions shall be null and void and
of no effect, except to the extent that such disposition is permitted by paragraph (a)(i); and

 

    11

     

    

 

(iii)          During
the lifetime of the Participant, only the Participant may exercise any exercisable portion of an Incentive Award granted to such Participant
under the Plan, unless it has been disposed of pursuant to a domestic relations order. After the death of the Participant, any exercisable
portion of an Incentive Award may, prior to the time when such portion becomes unexercisable under the Plan or the or award agreement,
be exercised by the Participant’s personal representative or by any person empowered to do so under the deceased Participant’s
will or under the then-applicable laws of descent and distribution.

 

(b)           Notwithstanding
paragraph (a) (i), the Committee, in its sole discretion, may determine to permit a Participant or an Allowed Transferee of the Participant
to transfer an Incentive Award to any one or more Allowed Transferees of such Participant, subject to the following terms and conditions:
(i) an Incentive Award transferred to an Allowed Transferee shall not be assignable or transferable by the Allowed Transferee other than
(A) to another Allowed Transferee of the applicable Participant or (B) by will or the laws of descent and distribution or, subject to
the consent of the Committee, pursuant to a domestic relations order; (ii) an Incentive Award transferred to an Allowed Transferee shall
continue to be subject to all the terms and conditions of the Incentive Award as applicable to the original Participant (other than the
ability to further transfer the Incentive Award to any person other than another Allowed Transferee); (iii) the Participant (or transferring
Allowed Transferee) and the receiving Allowed Transferee shall execute any and all documents requested by the Committee, including, without
limitation documents to (A) confirm the status of the Allowed Transferee as a “family member” of the Participant, (B) satisfy
any requirements for an exemption for the transfer under applicable law and (C) evidence the transfer; and (iv) any transfer of an
Incentive Award to an Allowed Transferee shall be without consideration, except as required by applicable law.

 

(c)           Notwithstanding
paragraph (a), a Participant may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant
and to receive any distribution with respect to any Incentive Award upon the Participant’s death. A beneficiary, legal guardian,
legal representative, or other person claiming any rights pursuant to the Plan is subject to all terms and conditions of the Plan or any
award agreement applicable to the Participant and any additional restrictions deemed necessary or appropriate by the Committee. If the
Participant is married or a domestic partner in a domestic partnership qualified under applicable law and resides in a community property
state, a designation of a person other than the Participant’s spouse or domestic partner, as applicable, as the Participant’s
beneficiary with respect to more than 50% of the Participant’s interest in the Incentive Award shall not be effective without the
prior written or electronic consent of the Participant’s spouse or domestic partner. If no beneficiary has been designated or survives
the Participant, payment shall be made to the person entitled thereto pursuant to the Participant’s will or the laws of descent
and distribution. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time; provided
that the change or revocation is delivered in writing to the Administrator prior to the Participant’s death.

 

18.          Section
409A.

 

To the extent that the
Committee determines that any Incentive Award granted under the Plan is subject to Section 409A, the Plan and the award agreement
evidencing such Incentive Award shall incorporate the terms and conditions required by Section 409A. In that regard, to the extent
any Incentive Award under the Plan or any other compensatory plan or arrangement of the Company or any of its Affiliates is subject
to Section 409A, and such Incentive Award or other amount is payable on account of a Participant’s termination of service,
then (a) such Incentive Award or amount shall only be paid to the extent such termination of service qualifies as a
 “separation from service” as defined in Section 409A, and (b) if such Incentive Award or amount is payable to a
 “specified employee” as defined in Section 409A then to the extent required in order to avoid a prohibited distribution
under Section 409A, such Incentive Award or other compensatory payment shall not be payable prior to the earlier of (i) the
expiration of the six-month period measured from the date of the Participant’s termination of service, or (ii) the date of the
Participant’s death. To the extent applicable, the Plan and any award agreements shall be interpreted in accordance with
Section 409A. Notwithstanding any provision of the Plan to the contrary, in the event that following the date the Plan is adopted by
the Board of Directors the Committee determines that any Incentive Award may be subject to Section 409A, the Committee may (but is
not obligated to), without a Participant’s consent, adopt such amendments to the Plan and the applicable award agreement or
adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other
actions, that the Committee determines are necessary or appropriate to (A) exempt the Incentive Award from Section 409A and/or
preserve the intended tax treatment of the benefits provided with respect to the Incentive Award, or (B) comply with the
requirements of Section 409A and thereby avoid the application of any penalty taxes under Section 409A. The Company makes no
representations or warranties as to the tax treatment of any Incentive Award under Section 409A or otherwise. The Company shall have
no obligation under this Section 18 or otherwise to take any action (whether or not described herein) to avoid the imposition
of taxes, penalties or interest under Section 409A with respect to any Incentive Award and shall have no liability to any
Participant or any other person if any Incentive Award, compensation or other benefits under the Plan are determined to constitute
non-compliant, “nonqualified deferred compensation” subject to the imposition of taxes, penalties and/or interest under
Section 409A.

 

    12

     

    

 

19.           Expenses
and Receipts.

 

The expenses of the Plan shall
be paid by the Company. Any proceeds received by the Company in connection with any Incentive Award will be used for general corporate
purposes.

 

20.          Governing
Law.

 

The Plan and the rights of
all persons under the Plan shall be construed and administered in accordance with the laws of the State of Delaware, without regard to
its conflict of law principles.

 

21.           Effective
Date and Term of Plan.

 

The Prior 2016 Plan was amended
on December 14, 2021 and was further amended and restated on March 7, 2022 in the form herein following approval by the Board of
Directors, in each case subject to approval by the Company’s shareholders. No grants may be made under the Plan after March 7,
2032.

 

The Plan, as amended and restated
on March 7, 2022, shall be submitted for the approval of the Company’s shareholders no later than March 7, 2023. Incentive
Awards may be granted or awarded following March 7, 2022 and prior to such shareholder approval; provided that such Incentive Awards
shall not be exercisable, shall not vest and the restrictions thereon shall not lapse and no Class A Shares shall be issued pursuant thereto
prior to the time when the Plan is approved by the Company’s shareholders; and provided, further, that if such approval has not
been obtained by March 7, 2023 all Incentive Awards previously granted or awarded under the Plan following March 7, 2022 or
otherwise if the terms of such Incentive Awards provide that the grant or exercise of the award is subject to shareholder approval shall
thereupon be canceled and become null and void.

 

If the Plan, as hereby amended
and restated, is not approved by the Company's shareholders, (i) no further Awards shall be granted hereunder, and (ii) the Plan as in
effect on June 25, 2020 will continue in full force and effect in accordance with its terms.

 

    13Exhibit 10.1

 

To subscribe for Common Stock and Warrants in
the private offering of

 

ODYSSEY HEALTH, INC.

 

		1.	Date and Fill in the number of shares of Common Stock, par value $0.001 per share of the Company
(the “Shares”) and associated warrant (the “Warrants” and, collectively with the Shares,
the “Securities”) to purchase one-half of a share of Common Stock, at a combined purchase price of $0.35 per
Share and associated Warrant being subscribed for and Complete and Sign the Signature Page included in this Subscription Agreement.

 

		2.	Initial the Accredited Investor Questionnaire attached to this Subscription Agreement as Exhibit
A in the appropriate spaces.

 

		3.	Complete and Sign the Signature Page attached to this Subscription Agreement. NOTICE: Please note that
by executing the attached Subscription Agreement, you will be deemed to have executed the Securities Purchase Agreement (Exhibit B
to this Subscription Agreement), (together with the Memorandum, the Securities Purchase Agreement, the Registration Rights Agreement and
the Warrant are collectively referred to herein as the “Transaction Documents”), each of which are attached to the Memorandum,
and will be treated for all purposes as if you did sign each such Transaction Document even though you may not have physically signed
the signature pages to such documents. 

 

		4.	Complete and Return the Accredited Investor Questionnaire attached to this Subscription Agreement
as Exhibit A.

 

		5.	Return all forms to your Account Executive and then send all signed original documents with a check
(if applicable) to:

 

Laidlaw & Company (UK)
Ltd.

Attn: Investment Banking

521 Fifth Avenue, 12th Floor

New York, NY 10175

 

		6.	Please make your subscription payment payable to the order of “Signature Bank, as Escrow Agent
for Odyssey Health, Inc.” Account No. [ ].
	 	 	 
	 	 	For wiring
funds directly to the escrow account, use the following instructions:

 

Signature Bank

Acct. Name: Signature Bank, as
Escrow Agent for Odyssey Health, Inc.

ABA Number: 026013576

SWIFT Code: SIGNUS33

A/C Number: [ ]

FBO:   Purchaser Name 

             Social Security Number

             Address

 

ALL SUBSCRIPTION DOCUMENTS MUST BE FILLED IN AND SIGNED EXACTLY
AS SET FORTH WITHIN.

 

 

 

    	 	1	 

     

    

 

SUBSCRIPTION AGREEMENT

 

FOR

 

ODYSSEY HEALTH, INC.

 

Dated: [ ], 2022

 

Odyssey Health, Inc.

c/o Laidlaw & Company (UK) Ltd.

521 Fifth Avenue, 12th Floor

New York, NY 10175

 

Ladies and Gentlemen:

 

1. Subscription. The
undersigned (the “Purchaser”) will purchase the number of shares of Common Stock, par value $0.001 per share,
(the “Shares”) and associated warrant (the “Warrants” and, collectively with the Shares,
the “Securities”) to purchase one-half of a share of Common Stock, of Odyssey Health, Inc., a Nevada corporation
(the “Company”), set forth on the signature page to this Subscription Agreement, at a purchase price of $0.35
per Share and associated Warrant. The Securities are being offered (the “Offering”) by the Company pursuant
to the offering terms set forth in the Company’s Confidential Private Placement Memorandum, dated as of [ ], 2022, as may
be amended and/or supplemented, from time to time (collectively, the “Memorandum”).

 

The Securities are being offered
on a “best efforts, all or none” basis with respect to the minimum of $999,999.70 (the “Minimum Offering
Amount”), and thereafter on a “reasonable best efforts” basis up to the maximum of $4,999,999.90 (the
“Maximum Offering Amount”), which Maximum Offering Amount may be increased to up to $5,999,999.95 upon agreement
of the Company and the Introducing Broker; provided, that, the Company may terminate the Offering at any time even if the Securities
having an aggregate purchase price of $4,999,999.90 ($5,999,999.95 if such increase is implemented in full) have not been sold.

 

The Initial Closing (as defined
herein) of this Offering shall be subject to subscriptions being received from qualified investors and accepted by the Company. Upon acceptance
by the Company after the date hereof of subscriptions for the Minimum Offering Amount, Laidlaw & Company (UK) Ltd. (“Laidlaw”
or the “Introducing Broker”) and the Company shall have the right at any time thereafter, prior to the termination
of the Offering Period (as defined below), to effect an initial closing with respect to this Offering (the “Initial Closing”).
Thereafter, the Introducing Broker and the Company shall continue to accept, and continue to have closings (together with the Initial
Closing, each a “Closing”) for, additional subscriptions for Securities from investors from time to time.

The Offering will commence
on the date of this Memorandum and continue through the earlier of (i) the date upon which subscriptions for the Maximum Offering Amount
(which, for the avoidance of doubt, shall equal $4,999,999.90 (or up to $5,999,999.95 if the related increase is implemented in full)
offered hereunder have been accepted, (ii) [ ], 2022, or (iii) the date upon which the Company and the Introducing Broker (as defined
herein) elect to terminate the Offering (the “Offering Period”).

 

The minimum investment amount
that may be purchased by an investor is 285,715 Shares (and associated Warrants) at a price of $100,000.25 (the “Investor
Minimum Investment”); provided however, the Company and the Introducing Broker, in their mutual discretion, may accept an
investor subscription for an amount less than the Investor Minimum Investment. The subscription for the Securities will be made in accordance
with and subject to the terms and conditions of this Subscription Agreement and the Memorandum.

 

 

 

 

    	 	2	 

     

    

 

All subscription funds will be held in a non-interest
bearing escrow account in the Company’s name at Signature Bank (the “Escrow Agent”), 261 Madison Ave.,
New York, NY 10016, or with such other escrow agent as may be appointed by Laidlaw and the Company (the “Escrow Account”).

 

In the event that (i) subscriptions
for the Offering are rejected in whole (at the sole discretion of the Company), (ii) the Minimum Offering Amount has not been subscribed
for prior to [ ], 2022, or (iii) the Offering is otherwise terminated by the Company or the Introducing Broker prior to the expiration
of the Offering Period or, if extended, prior to the Termination Date, then the Escrow Agent will refund all subscription funds held
in the Escrow Account to the persons who submitted such funds, without interest, penalty or deduction. If a subscription is rejected
in part (at the sole discretion of the Company or Laidlaw) and the Company accepts the portion not so rejected, the funds for the rejected
portion of such subscription will be returned without interest, penalty, expense or deduction.

 

Laidlaw and the Company each
reserves the right (but is not obligated) to have its employees, agents, officers, directors and affiliates of Laidlaw or the Company
purchase the Securities in the Offering and all such purchases will be counted towards the Minimum Offering Amount and the Maximum Offering
Amount.

 

The terms of the Offering
are more completely described in the Memorandum and such terms are incorporated herein in their entirety. Certain capitalized terms used,
but not otherwise defined herein, will have the respective meanings provided in the Memorandum.

 

2.       Payment.
The Purchaser encloses herewith a check payable to, or will immediately make a wire transfer payment to, “Signature Bank,
as Escrow Agent for Odyssey Health, Inc.,” in the full amount of the purchase price of the Securities being subscribed for.
Together with the check for, or wire transfer of, the full purchase price, the Purchaser is delivering a completed and executed Signature
Page to this Subscription Agreement along with a completed and executed Accredited Investor Questionnaire, which is attached hereto as
Exhibit A. By executing this Subscription Agreement (this “Subscription Agreement”), you will also
be deemed to have executed each of the Securities Purchase Agreement in the form of Exhibit B to this Subscription Agreement and
the Registration Rights Agreement in the form of Exhibit C to this Subscription Agreement (this Subscription Agreement, together
with the Memorandum, the Securities Purchase Agreement, the Registration Rights Agreement and the Warrant are collectively referred to
herein as the “Transaction Documents”), and will be bound by the respective terms of each of them.

 

3.       Deposit
of Funds. All payments made as provided in Section 2 hereof will be deposited by the Purchaser as soon as practicable with
the Escrow Agent, or such other escrow agent appointed by Laidlaw and the Company, in the Escrow Account. In the event that the Company
does not effect a Closing during the Offering Period, the Escrow Agent will refund all subscription funds, without deduction and/or interest
accrued thereon, and will return the subscription documents to each Purchaser. If the Company or Laidlaw rejects a subscription, either
in whole or in part (at the sole discretion of the Company or Laidlaw), the rejected subscription funds or the rejected portion thereof
will be returned promptly to such Purchaser without interest, penalty, expense or deduction.

 

4.       Acceptance
of Subscription. The Purchaser understands and agrees that the Company or Laidlaw, each in its sole discretion, reserves the right
to reject this or any other subscription for the Securities, in whole or in part, notwithstanding prior receipt by the Purchaser of notice
of acceptance of this or any other subscription. The Company will have no obligation hereunder until the Company executes an executed
copy of the Subscription Agreement. If Purchaser’s subscription is rejected in whole (at the sole discretion of the Company or Laidlaw),
the Offering is terminated or the Minimum Offering Amount is not subscribed for and accepted prior to the expiration of the Offering Period,
all funds received from the Purchaser will be returned without interest, penalty, expense or deduction, and this Subscription Agreement
will thereafter be of no further force or effect. If Purchaser’s subscription is rejected in part (at the sole discretion of the
Company or Laidlaw) and the Company accepts the portion not so rejected, the funds for the rejected portion of such subscription will
be returned without interest, penalty, expense or deduction, and this Subscription Agreement will continue in full force and effect to
the extent such subscription was accepted. The Purchaser may revoke its subscription and obtain a return of the subscription amount paid
to the Escrow Account at any time before the date of the Initial Closing. The Purchaser may not revoke this subscription or obtain a return
of the subscription amount paid to the Escrow Agent on or after the date of the Initial Closing. Any subscription received after the Initial
Closing but prior to the Termination Date shall be irrevocable.

 

 

 

    	 	3	 

     

    

 

5.       Representations
and Warranties of the Purchaser. The Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)       None
of the Securities are registered under the Securities Act of 1933, as amended (the “Securities Act”), or any
state securities laws. The Purchaser understands that the offering and sale of the Securities is intended to be exempt from registration
under the Securities Act, by virtue of Section 4(a)(2) thereof and the provisions of Regulation D promulgated thereunder, based, in part,
upon the representations, warranties and agreements of the Purchaser contained in this Subscription Agreement and the Securities Purchase
Agreement;

 

(b)       The
Purchaser and the Purchaser’s attorney, accountant, purchaser representative and/or tax advisor, if any (collectively, “Advisors”),
have received and have carefully reviewed the Memorandum, this Subscription Agreement, and each of the Transaction Documents and all other
documents requested by the Purchaser or its Advisors, if any, and understand the information contained therein, prior to the execution
of this Subscription Agreement;

 

(c)       Neither
the Securities and Exchange Commission (the “Commission”) nor any state securities commission has approved or
disapproved of the Securities or passed upon or endorsed the merits of the Offering or confirmed the accuracy or determined the adequacy
of the Memorandum. The Memorandum has not been reviewed by any Federal, state or other regulatory authority. Any representation to the
contrary may be a criminal offense;

 

(d)       All
documents, records, and books pertaining to the investment in the Securities including, but not limited to, all information regarding
the Company and the Securities, have been made available for inspection and reviewed by the Purchaser and its Advisors, if any;

 

(e)       The
Purchaser and its Advisors, if any, have had a reasonable opportunity to ask questions of and receive answers from the Company’s
officers and any other persons authorized by the Company to answer such questions, concerning, among other related matters, the Offering,
the Securities, the Transaction Documents and the business, financial condition, results of operations and prospects of the Company and
all such questions have been answered by the Company to the full satisfaction of the Purchaser and its Advisors, if any;

 

(f)       In
evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or other information
(oral or written) other than as stated in the Memorandum;

 

(g)       The
Purchaser is unaware of, is in no way relying on, and did not become aware of the offering of the Securities through or as a result of,
any form of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication
published in any newspaper, magazine or similar media or broadcast over television, radio or over the Internet, in connection with the
offering and sale of the Securities and is not subscribing for the Securities and did not become aware of the Offering through or as a
result of any seminar or meeting to which the Purchaser was invited by, or any solicitation of a subscription by, a person not previously
known to the Purchaser in connection with investments in securities generally;

 

(h)       The
Purchaser has taken no action which would give rise to any claim by any person for brokerage commissions, finders’ fees or the like
relating to this Subscription Agreement or the transactions contemplated hereby (other than fees to be paid by the Company to Laidlaw,
as described in the Memorandum);

 

(i)       The
Purchaser, either alone or together with its Advisors, if any, has such knowledge and experience in financial, tax, and business matters,
and, in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with the
Offering to evaluate the merits and risks of an investment in the Securities and the Company and to make an informed investment decision
with respect thereto;

 

(j)       The
Purchaser is not relying on the Company, Laidlaw or any of their respective employees or agents with respect to the legal, tax, economic
and related considerations of an investment in any of the Securities and the Purchaser has relied on the advice of, or has consulted with,
only its own Advisors;

 

 

 

 

    	 	4	 

     

    

 

(k)       The
Purchaser is acquiring the Securities solely for such Purchaser’s own account for investment and not with a view to resale or distribution
thereof, in whole or in part. The Purchaser has no agreement or arrangement, formal or informal, with any person to sell or transfer all
or any part of any of the Securities and the Purchaser has no plans to enter into any such agreement or arrangement;

 

(l)       The
Purchaser understands and agrees that purchase of the Securities is a high risk investment and the Purchaser is able to afford an investment
in a speculative venture having the risks and objectives of the Company. The Purchaser must bear the substantial economic risks of the
investment in the Securities indefinitely because none of the Securities may be sold, hypothecated or otherwise disposed of unless subsequently
registered under the Securities Act and applicable state securities laws or an exemption from such registration is available. Legends
will be placed on the certificates representing the Securities to the effect that such securities have not been registered under the Securities
Act or applicable state securities laws and appropriate notations thereof will be made in the Company’s books. Additionally, Purchaser
understands that there is presently no public market for the Warrants and a public market may never develop for the Warrants;

 

(m)       The
Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies and has no
need for liquidity from its investment in the Securities for an indefinite period of time;

 

(n)       The
Purchaser is aware that an investment in the Securities involves a number of very significant risks and has carefully read and considered
the matters set forth in the Memorandum and, in particular, the matters under the caption “Risk Factors” therein and understands
any of such risk may materially adversely affect the Company’s operations and future prospects;

 

(o)       
At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises
any Warrants it will be, an “accredited investor” within the meaning of Regulation D, Rule 501(a), promulgated by the Securities
and Exchange Commission under the Securities Act and has truthfully and accurately completed the Accredited Investor Questionnaire attached
as Exhibit A to this Subscription Agreement and will submit to the Company such further assurances of such status as may be reasonably
requested by the Company;

 

(p)       The
Purchaser: (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority to execute
and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof;
(ii) if a corporation, partnership, or limited liability company, or association, joint stock company, trust, unincorporated organization
or other entity, represents that such entity was not formed for the specific purpose of acquiring the Securities, such entity is duly
organized, validly existing and in good standing under the laws of the state of its organization, the consummation of the transactions
contemplated hereby is authorized by, and will not result in a violation of state law or its charter or other organizational documents,
such entity has full power and authority to execute and deliver this Subscription Agreement and all other related agreements or certificates
and to carry out the provisions hereof and thereof and to purchase and hold the Securities, the execution and delivery of this Subscription
Agreement has been duly authorized by all necessary action, this Subscription Agreement has been duly executed and delivered on behalf
of such entity and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription Agreement in a representative
or fiduciary capacity, represents that it has full power and authority to execute and deliver this Subscription Agreement in such capacity
and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited liability company or partnership,
or other entity for whom the Purchaser is executing this Subscription Agreement, and such individual, partnership, ward, trust, estate,
corporation, or limited liability company or partnership, or other entity has full right and power to perform pursuant to this Subscription
Agreement and make an investment in the Company, and represents that this Subscription Agreement constitutes a legal, valid and binding
obligation of such entity. The execution and delivery of this Subscription Agreement will not violate or be in conflict with any order,
judgment, injunction, agreement or controlling document to which the Purchaser is a party or by which it is bound;

 

(q)       The
Purchaser and its Advisors, if any, have had the opportunity to obtain any additional information, to the extent the Company had such
information in its possession or could acquire it without unreasonable effort or expense, necessary to verify the accuracy of the information
contained in the Memorandum including, but not limited to, the terms and conditions of the Securities as set forth therein and the Transaction
Documents and all other related documents, received or reviewed in connection with the purchase of the Securities and have had the opportunity
to have representatives of the Company provide them with such additional information regarding the terms and conditions of this particular
investment and the financial condition, results of operations, business and prospects of the Company deemed relevant by the Purchaser
or its Advisors, if any, and all such requested information, to the extent the Company had such information in its possession or could
acquire it without unreasonable effort or expense, has been provided by the Company in writing to the full satisfaction of the Purchaser
and its Advisors, if any;

 

 

 

    	 	5	 

     

    

 

(r)       The
Purchaser represents to the Company that any information which the undersigned has heretofore furnished or is furnishing herewith to the
Company is complete and accurate and may be relied upon by the Company in determining the availability of an exemption from registration
under Federal and state securities laws in connection with the offering of securities as described in the Memorandum;

 

(s)       The
Purchaser has significant prior investment experience, including investment in non-listed and unregistered securities. The Purchaser has
a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The Purchaser’s
overall commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net worth and financial
circumstances and the purchase of the Securities will not cause such commitment to become excessive. This investment is a suitable one
for the Purchaser;

 

(t)       The
Purchaser is satisfied that it has received adequate information with respect to all matters which it or its Advisors, if any, consider
material to its decision to make this investment;

 

(u)       The
Purchaser acknowledges that any and all estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company in good faith, but that the attainment of any such projections, estimates or forward-looking statements cannot be guaranteed,
will not be updated by the Company and should not be relied upon;

 

(v)       No
oral or written representations have been made, or oral or written information furnished, to the Purchaser or its Advisors, if any, in
connection with the offering of the Securities which are in any way inconsistent with the information contained in the Memorandum;

 

(w)       Within
five (5) days after receipt of a request from the Company, the Purchaser will provide such information and deliver such documents as may
reasonably be necessary to comply with any and all laws and ordinances to which the Company is subject;

 

(x)       THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF CERTAIN STATES AND ARE BEING OFFERED
AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID ACT AND SUCH LAWS PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY
OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY
OR ADEQUACY OF THE MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

(y)       In
making an investment decision, investors must rely on their own examination of Company and the terms of the Offering, including the merits
and risks involved. Investors should be aware that they will be required to bear the financial risks of this investment for an indefinite
period of time;

 

(z)       (For
ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed
of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan assets
and impose other fiduciary responsibilities. The Purchaser or Plan fiduciary (a) is responsible for the decision to invest in the Company;
(b) is independent of the Company and any of its affiliates; (c) is qualified to make such investment decision; and (d) in making such
decision, the Purchaser or Plan fiduciary has not relied on any advice or recommendation of the Company or any of its affiliates; and

 

(aa)      The
Purchaser has read in its entirety the Memorandum and all exhibits thereto, including, but not limited to, all information relating to
the Company, and the Securities, and understands fully to its full satisfaction all information included in the Memorandum including,
but not limited to, the Section entitled “Risk Factors”.

 

 

 

    	 	6	 

     

    

 

(bb)       The
Purchaser represents that (i) the Purchaser was contacted regarding the sale of the Securities by the Company or the Introducing Broker
(or another person whom the Purchaser believed to be an authorized agent or representative thereof) with whom the Purchaser had a prior
substantial pre-existing relationship and (ii) it did not learn of the offering of the Securities by means of any form of general solicitation
or general advertising, and in connection therewith, the Purchaser did not (A) receive or review any advertisement, article, notice or
other communication published in a newspaper or magazine or similar media or broadcast over television or radio, whether closed circuit,
or generally available; or (B) attend any seminar meeting or industry investor conference whose attendees were invited by any general
solicitation or general advertising;

 

(cc)       The
Purchaser consents to the placement of a legend on any certificate or other document evidencing the Securities and, that such securities
have not been registered under the Securities Act or any state securities or “blue sky” laws and setting forth or referring
to the restrictions on transferability and sale thereof contained in this Agreement. The Purchaser is aware that the Company will make
a notation in its appropriate records with respect to the restrictions on the transferability of such Securities. The legend to be placed
on each certificate shall be in form substantially similar to the following:

 

[“[NEITHER] THIS SECURITY [NOR
THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE]] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE COMPANY TO SUCH EFFECT, THE
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION] OF THIS
SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH
SECURITIES.]

 

(dd)       The Purchaser acknowledges
that if he or she is a Registered Representative of a Financial Industry Regulatory Authority (“FINRA”) member firm, he or
she must give such firm the notice required by the FINRA’s Rules of Fair Practice, receipt of which must be acknowledged by such
firm prior to an investment in the Securities.

 

(ee)       To effectuate the terms
and provisions hereof, the Purchaser hereby appoints the Introducing Broker as its attorney-in-fact (and the Introducing Broker hereby
accepts such appointment) for the purpose of carrying out the provisions of the Escrow Agreement by and between the Company, the Introducing
Broker and the Escrow Agent (the “Escrow Agreement”) including, without limitation, taking any action on behalf
of, or at the instruction of, the Purchaser and executing any release notices required under the Escrow Agreement and taking any action
and executing any instrument that the Introducing Broker may deem necessary or advisable (and lawful) to accomplish the purposes hereof.
All acts done under the foregoing authorization are hereby ratified and approved and neither the Introducing Broker nor any designee nor
agent thereof shall be liable for any acts of commission or omission, for any error of judgment, for any mistake of fact or law except
for acts of gross negligence or willful misconduct. This power of attorney, being coupled with an interest, is irrevocable while the Escrow
Agreement remains in effect.

 

(ff)       The Purchaser agrees
not to issue any public statement with respect to the Offering, Purchaser’s investment or proposed investment in the Company or
the terms of any agreement or covenant between them and the Company without the Company’s prior written consent, except such disclosures
as may be required under applicable law.

 

 

 

 

    	 	7	 

     

    

 

(gg)       The Purchaser understands,
acknowledges and agrees with the Company that this subscription may be rejected, in whole or in part, by the Company, in the sole and
absolute discretion of the Company, at any time before any Closing notwithstanding prior receipt by the Purchaser of notice of acceptance
of the Purchaser’s subscription.

 

(hh)       The Purchaser acknowledges
that the information contained in the Transaction Documents or otherwise made available to the Purchaser is confidential and non-public
and agrees that all such information shall be kept in confidence by the Purchaser and neither used by the Purchaser for the Purchaser’s
personal benefit (other than in connection with this subscription) nor disclosed to any third party for any reason, notwithstanding that
a Purchaser’s subscription may not be accepted by the Company; provided, however, that (a) the Purchaser may disclose such information
to its affiliates and advisors who may have a need for such information in connection with providing advice to the Purchaser with respect
to its investment in the Company so long as such affiliates and advisors have an obligation of confidentiality, and (b) this obligation
shall not apply to any such information that (i) is part of the public knowledge or literature and readily accessible at the date hereof,
(ii) becomes part of the public knowledge or literature and readily accessible by publication (except as a result of a breach of this
provision) or (iii) is received from third parties without an obligation of confidentiality (except third parties who disclose such information
in violation of any confidentiality agreements or obligations, including, without limitation, any subscription or other similar agreement
entered into with the Company).

 

6.       Representations
and Warranties of the Company. The representations and warranties contained in Section 3 of the Securities Purchase Agreement to be
entered into between the Company and the Purchasers are incorporated herein by reference and are deemed to be made under this Subscription
Agreement.

 

7.       Indemnification.
The Purchaser agrees to indemnify and hold harmless the Company, Laidlaw and each of their respective officers, directors, managers, employees,
agents, attorneys, control persons and affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses
whatsoever (including, but not limited to, any and all expenses incurred in investigating, preparing or defending against any litigation
commenced or threatened) based upon or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation
or omission to state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other
document delivered in connection with this Subscription Agreement.

 

8.       Binding
Effect. This Subscription Agreement will survive the death or disability of the Purchaser and will be binding upon and inure to the
benefit of the parties and their heirs, executors, administrators, successors, legal representatives, and permitted assigns. If the Purchaser
is more than one person, the obligations of the Purchaser hereunder will be joint and several and the agreements, representations, warranties
and acknowledgments herein will be deemed to be made by and be binding upon each such person and such person’s heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

9.       Modification.
This Subscription Agreement will not be modified or waived except by an instrument in writing signed by the party against whom any such
modification or waiver is sought.

 

10.      Notices.
Any notice or other communication required or permitted to be given hereunder will be in writing and will be mailed by certified mail,
return receipt requested, sent by email or facsimile (with confirmation of delivery), or delivered by reputable overnight courier such
as FedEx against receipt to the party to whom it is to be given (a) if to the Company, at the address set forth in the Securities Purchase
Agreement or (b) if to the Purchaser, at the address set forth on the signature page hereof (or, in either case, to such other address
as the party will have furnished in writing in accordance with the provisions of this Section 10). Any notice or other communication given
by certified mail will be deemed given at the time of certification thereof, except for a notice changing a party’s address which
will be deemed given at the time of receipt thereof. Any notice or other communication given by e-mail will be deemed given upon confirmation
of delivery. Any notice or other communication given by overnight courier will be deemed given at the time of delivery.

 

 

 

 

    	 	8	 

     

    

 

11.       Assignability.
This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the Purchaser and
the transfer or assignment of any of the Securities will be made only in accordance with all applicable laws.

 

12.       Applicable
Law.  This Subscription Agreement will be governed by and construed under the laws of the State of New York as applied to agreements
among New York residents entered into and to be performed entirely within New York. The parties hereto (1) agree that any legal suit,
action or proceeding (a “Proceeding”) arising out of or relating to this Subscription Agreement will be instituted
exclusively in the federal and state courts sitting in the State of New York, Borough of Manhattan (such
court, and of the appropriate appellate courts therefrom, the “Designated Court”), (2) waive any objection
which the parties may have now or hereafter to the venue of any such Proceeding, and (3) irrevocably consent to the jurisdiction of such
Designated Court in any such Proceeding. Each of the parties hereto further agrees to accept and acknowledge service of any and all process
which may be served in any such Proceeding in the Designated Court and agrees that service of process upon it mailed by certified mail
to its address will be deemed in every respect effective service of process upon it, in any such Proceeding. THE PARTIES HERETO AGREE
TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS SUBSCRIPTION AGREEMENT
OR ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY.

 

13.       Blue
Sky Qualification. The purchase of Securities pursuant to this Subscription Agreement is expressly conditioned upon the exemption
from qualification of the offer and sale of the Securities from applicable federal and state securities laws.

 

14.       Use
of Pronouns. All pronouns and any variations thereof used herein will be deemed to refer to the masculine, feminine, neuter, singular
or plural as the identity of the person or persons referred to may require.

 

15.       Confidentiality.
The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company not otherwise
properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose, except as may
be required by law or for the performance of this Subscription Agreement, or use to the detriment of the Company or for the benefit of
any other person or persons, or misuse in any way, any confidential information of the Company, including any trade or business secrets
of the Company and any business materials that are treated by the Company as confidential or proprietary, including, without limitation,
confidential information obtained by or given to the Company about or belonging to third parties.

 

16.       Miscellaneous.

 

(a)       This
Subscription Agreement, together with the other Transaction Documents, constitute the entire agreement between the Purchaser and the Company
with respect to the subject matter hereof and supersede all prior oral or written agreements and understandings, if any, relating to the
subject matter hereof. The terms and provisions of this Subscription Agreement may be waived, or consent for the departure therefrom granted,
only by a written document executed by the party entitled to the benefits of such terms or provisions.

 

(b)       Each
of the Purchaser’s and the Company’s representations and warranties made in this Subscription Agreement will survive the execution
and delivery hereof and delivery of the Securities.

 

(c)       Each
of the parties hereto will pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others engaged
by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not the transactions
contemplated hereby are consummated. Notwithstanding anything to the contrary herein, the Company shall pay the legal fees of its counsel
in connection with the rendering of any legal opinions to remove the restrictive legend from any of the Securities.

 

(d)       This
Subscription Agreement may be executed in one or more counterparts each of which will be deemed an original, but all of which will together
constitute one and the same instrument.

 

 

 

 

    	 	9	 

     

    

 

(e)       Each
provision of this Subscription Agreement will be considered separable and, if for any reason any provision or provisions hereof are determined
to be invalid or contrary to applicable law, such invalidity or illegality will not impair the operation of or affect the remaining portions
of this Subscription Agreement.

 

(f)       Paragraph
titles are for descriptive purposes only and will not control or alter the meaning of this Subscription Agreement as set forth in the
text.

 

17.       Signature
Page. It is hereby agreed by the parties hereto that the execution by the Purchaser of this Subscription Agreement, in the place set forth
hereinbelow, will be deemed and constitute the agreement by the Purchaser to be bound by all of the terms and conditions hereof as well
as by the Securities Purchase Agreement and each of the other Transaction Documents, and will be deemed and constitute the execution by
the Purchaser of all such Transaction Documents without requiring the Purchaser’s separate signature on any of such Transaction
Documents.

 

[Remainder of page intentionally left blank.]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	10	 

     

    

 

ANTI-MONEY LAUNDERING REQUIREMENTS

 

	
    The USA PATRIOT Act

     
	What is money laundering?	How big is the problem and why is it important?
	
     

    The USA PATRIOT Act is designed to detect, deter,
    and punish terrorists in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage firms and financial
    institutions. Since April 24, 2002 all brokerage firms have been required to have new, comprehensive anti-money laundering programs. To
    help you understand these efforts, we want to provide you with some information about money laundering and our steps to implement the
    USA PATRIOT Act.
	
     

    Money laundering is the process of disguising
    illegally obtained money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in connection
    with a wide variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.
	
     

    The use of the U.S. financial system by criminals
    to facilitate terrorism or other crimes could well taint our financial markets. According to the U.S. State Department, one recent estimate
    puts the amount of worldwide money laundering activity at $1 trillion a year.

 

	What are we required to do to eliminate money laundering?
	
     

    Under new rules required by the USA PATRIOT Act,
    our anti-money laundering program must designate a special compliance officer, set up employee training, conduct independent audits, and
    establish policies and procedures to detect and report suspicious transaction and ensure compliance with the new laws.
	
     

    As part of our required program, we may ask you
    to provide various identification documents or other information. Until you provide the information or documents we need, we may not be
    able to effect any transactions for you.

 

 

 

 

 

    	 	11	 

     

    

 

ODYSSEY HEALTH, INC.

SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT 

 

Purchaser
hereby elects to purchase a total of $_________________, representing ________ shares of Common Stock and associated Warrants at a combined
purchase price of $0.35 per share and associated Warrant (NOTE: to be completed by the Purchaser).

 

	 

                                                                                                                                                               If the Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

                                                                                 

	Purchaser:	 	 	 	 	 
	 	 	 	 	 	 	 
	 	Print Name	 	 	 	Social Security Number	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	Signature	 	Date	 	Mailing Address	 
	 	 	 	 	 	 	 
	
    Co-Purchaser (if applicable):

     
	 	 	 	 	 
	 	 	 	 	 	 	 
	 	Print Name	 	 	 	Social Security Number	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	Signature	 	Date	 	Address (if different from above)

                                                                      
	 

 

	If the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:
	 	 	
     

     
	 	 	 	 
	 	Name of Partnership, Corporation, Limited Liability Company or Trust	 	 	 	Federal Taxpayer Identification Number	 
	 	
     

    By:                                        
	
     

     
	 	 	 	 
	 	
     

    Name:                                     

     

    Title:                                     
	 	Date	 	 	 
	Business Address

 

AGREED AND ACCEPTED:

ODYSSEY HEALTH, INC.

 

	 
	By:	 	 	 	 	 
		Name:	 	 	Date	 
	 	Title:	 	 	 	 

 

 

 

    	 	12	 

     

    

 

Exhibit
A

 

FORM OF INVESTOR QUESTIONNAIRE

 

ODYSSEY HEALTH, INC.

 

For Individual Investors Only

 

(All individual investors must INITIAL
where appropriate. Where there are joint investors both parties must INITIAL):

 

	Initial _______ 	I certify that I have a “net worth” of at least $1 million either individually or through aggregating my individual holdings
and those in which I have a joint, community property or other similar shared ownership interest with my spouse. For purposes of calculating
net worth under this paragraph, (i) the primary residence shall not be included as an asset, (ii) to the extent that the indebtedness
that is secured by the primary residence is in excess of the fair market value of the primary residence, the excess amount shall be included
as a liability, and (iii) if the amount of outstanding indebtedness that is secured by the primary residence exceeds the amount outstanding
60 days prior to the execution of this Subscription Agreement, other than as a result of the acquisition of the primary residence, the
amount of such excess shall be included as a liability.

 

	Initial _______ 	I certify that I have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with
my spouse) and expect my income (or joint income, as appropriate) to reach the same level in the current year.
	 	 
	Initial _______	I certify that I am a director or executive officer of the Company.

 

For Non-Individual
Investors

 

(all Non-Individual
Investors must INITIAL where appropriate):

 

	Initial
_______	The undersigned certifies that it is a bank, as defined in Section 3(a)(2) of the Securities Act, whether acting in its
individual or fiduciary capacity.
	 	 
	Initial
_______	The undersigned certifies that it is a savings and loan association or other institution as defined in Section 3(a)(5)(A)
of the Securities Act, whether acting in its individual or fiduciary capacity.
	 	 
	Initial
_______	The undersigned certifies that it is a broker or dealer registered pursuant to Section 15 of the United States Securities
Exchange Act of 1934, as amended.
	 	 
	Initial
_______	The undersigned certifies that it is an insurance company as defined in Section 2(a)(13) of the Securities Act.
	 	 
	Initial
_______	The undersigned certifies that it is an investment company registered under the United States Investment Company Act of
1940, as amended.
	 	 

 

 

 

    	 	13	 

     

    

 

	Initial
_______	The undersigned certifies that it is a business development company as defined in Section 2(a)(48) of the United States
Investment Company Act of 1940, as amended.
	 	 
	Initial
_______	The undersigned certifies that it is a small business investment company licensed by the U.S. Small Business Administration
under Section 301(c) or (d) of the United States Small Business Investment Act of 1958, as amended.
	 	 
	Initial
_______	The undersigned certifies that it is a plan established and maintained by a state, its political subdivisions or any agency
or instrumentality of a state or its political subdivisions, for the benefit of its employees, with total assets in excess of U.S. $5,000,000.
	 	 
	Initial
_______	The undersigned certifies that it is an employee benefit plan within the meaning of the United States Employee Retirement
Income Security Act of 1974, as amended, in which the investment decision is made by a plan fiduciary, as defined in Section 3(21) of
such Act, which is either a bank, savings and loan association, insurance company or registered investment adviser, or an employee benefit
plan with total assets in excess of U.S. $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons who
are U.S. Accredited Investors.
	 	 
	Initial
_______	The undersigned certifies that it is a private business development company as defined in Section 202(a)(22) of the United
States Investment Advisers Act of 1940.
	 	 
	Initial
_______	The undersigned certifies that it is an organization described in Section 501(c)(3) of the United States Internal Revenue
Code of 1986, as amended, a corporation, a Massachusetts or similar business trust, or a partnership, not formed for the specific purpose
of acquiring the securities offered, with total assets in excess of U.S. $5,000,000.
	 	 
	Initial
_______	The undersigned
certifies that it is a trust, with total assets in excess of U.S. $5,000,000, not formed for the specific purpose of acquiring the securities
offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) under the Securities Act.
	 	 
	Initial
_______	The undersigned
certifies that it is an entity in which all of the equity owners meet the requirements of at least one of the above categories.

 

 

 

 

 

 

 

 

    	 	14	 

     

    

 

ODYSSEY HEALTH, INC.

 

Investor Questionnaire

(Must be completed by Purchaser)

 

Section A - Individual Purchaser
Information

 

Purchaser Name(s): ________________________________________________________________________

Individual executing Profile or Trustee: _______________________________________________________________________

Social Security Numbers / Federal I.D. Number: ________________________________________________________________________

Date of Birth: _________________ Marital Status: _________________

Joint Party Date of Birth:_________________ 

Investment Experience (Years): ___________

Annual Income: _________________ 

Net Worth: ________________

Home Street Address: ________________________________________________________________________

Home City, State & Zip Code: ________________________________________________________________________

Home Phone: ________________________ Home Fax: _____________________

Home Email: _______________________________

Employer: _______________________________________________________________

Employer Street Address: ________________________________________________________________________

Employer City, State & Zip Code: ________________________________________________________________________

Bus. Phone: __________________________ Bus. Fax: _______________________

Bus. Email: ________________________________

Type of Business: ________________________________________________________________________

LAIDLAW Account Executive / Outside Broker/Dealer: _______________________________________________________

Please check if you are a FINRA member
or affiliate of a FINRA member firm: _______

 

 

 

 

 

    	 	15	 

     

    

 

Section B – Entity Purchaser
Information

 

Purchaser Name(s): ________________________________________________________________________

Authorized Individual executing Profile or Trustee: _______________________________________________________________________

Social Security Numbers / Federal I.D. Number: _______________________________________________________________________

Investment Experience (Years): ___________

Annual Income: _______________ 

Net Worth: ________________

Was the Trust
formed for the specific purpose of purchasing the Securities?

[ ] Yes [ ] No

Principal Purpose (Trust)______________________________________

Type of Business: ________________________________________________________

Street Address: ________________________________________________________________________

City, State & Zip Code: ________________________________________________________________________

Phone: ________________________ Fax: ________________________

Email: __________________________

Laidlaw Account Executive / Outside Broker/Dealer:

______________________________________________________

Please check if you are a FINRA member
or affiliate of a FINRA member firm: _______

 

 

 

 

 

 

 

    	 	16	 

     

    

 

Section C – Purchaser Instructions
for Payments of any Dividends

 

		 	 	Please make any dividend and
  any other payment checks pursuant to the Securities to “[ ] c/f [Insert Investor Name]” and deliver such checks
  to Laidlaw so that they may deposit them into my Laidlaw brokerage account
	 	 	 	 
	 	 	 	Please
make out any dividend and any other payment checks pursuant to the Securities in the registered name of the Purchaser set forth in the
signature page to the Subscription Agreement for the Securities and mail such checks to me at the address specified in such signature
page.

 

Section D – Securities Delivery Instructions
(check one)

 

____ Please deliver my securities to Laidlaw for deposit into my brokerage
account.

 

____ Please deliver my securities to the address listed in the above
Investor Questionnaire.

 

____ Please deliver my securities to the below address:

______________________________________

______________________________________

______________________________________

______________________________________

 

 

Purchaser Signature _______________________________________   Date_______________

 

Joint Purchaser Signature (if applicable): ______________________   Date_______________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	17	 

     

    

 

Exhibit
B

 

Form
of Securities Purchase Agreement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	18	 

     

    

 

 

Exhibit
C

 

Form
of Registration Rights Agreement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	19	 

     

    

 

Exhibit
D

 

Wire
Instructions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]